NCT05652400View on ClinicalTrials.gov

HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia

Active, not recruitingOBSERVATIONAL
Enrollment

2,400

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

January 31, 2026

Conditions
HIV-1-infectionAntiretroviral Therapy
Interventions
OTHER

Exposure to antiretroviral therapy

Outcomes will be compared with regard to current or previous exposure to antiretroviral therapy.

Trial Locations (1)

Unknown

Public hospitals and health centers in the Adama uptake area, Ādama

All Listed Sponsors
collaborator

Armauer Hansen Research Institute, Ethiopia

OTHER

collaborator

Ethiopian Public Health Institute

OTHER_GOV

collaborator

Oromia Regional Health Bureau

UNKNOWN

lead

Lund University

OTHER